Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Ontvang nu dagelijks onze kooptips!

word abonnee

Cannabis aandelen

8.264 Posts
Pagina: «« 1 ... 222 223 224 225 226 ... 414 »» | Laatste | Omlaag ↓
  1. [verwijderd] 25 oktober 2018 17:55
    quote:

    Mikeydekh schreef op 25 oktober 2018 17:50:

    Maar nu even serieus. Als ik alle artikelen die ik lees een beetje kan samenvatten, komt het er bij Aurora op neer dat zij missen wat Canopy bijvoorbeeld wel heeft. Een grote partner die wil investeren en samenwerken. Dat zou de koers van Aurora heel veel goed doen.
    ja daar is het wachten op en als die komt dan kan het hard gaan maar wanneer komt dit bericht.

    heb allang niets meer vernomen van de ceo's van de meeste fondsen, zijn ze geld aan het tellen in de zon met een cocktail?
  2. Osho 25 oktober 2018 18:57
    Kwam een bericht op het internet tegen. Een mooi overzicht waar Aurora allemaal bij betrokken is:

    ''Some solid facts for investors I came across this morning. I'm paying less attention to the market atm and keeping this in mind for the long haul.''

    1. Aurora Sky – 800,000 sq. ft. purpose-built greenhouse – 100,000 kg plus cannabis; $1 billion revenue; on airport property for ease of shipping; 90% licensed to produce and sell will be 100% by end of December
    2. Aurora Sun – 1.2 million sp. ft. purpose built greenhouse 120,000 kg cannabis $1 billion plus revenue under construction fully funded
    3. Aurora Nordic – 51% Aurora 49% Alfred Pedersen & Son 100,000 sq. ft. purpose built greenhouse; summer 2018; 1,000,000 sq. ft. purpose built greenhouse; 120,000 kg of cannabis; $1 billion plus revenue; now growing in Denbmark/Europe under construction fully funded
    4. Aurora Mountain - 55,200 sq. ft. purpose built greenhouse
    5. Aurora Vie – 44,000 sq. ft. purpose built greenhouse
    6. Lachute Facility - 48,000 purpose built greenhouse 4,500 kg
    7. H2 Biopharma – 100% owner; Sits on 46 acres H2 Biopharma may purchase for $136,000CAD
    8. CanniMed – 7,000 kg of production EU GMP Certified; patients 22,000; patents; Intellectual property…. came with $65 million cash
    9. MedReleaf – Markham 7,000 kg; Bradford 28,000 kg; Exeter 105,000 kg with potential to double in size; came with $256 million in cash; 40,000 patients
    10. Peloton Pharmaceuticals – 100% ownership
    11. CanvasRx Holdings – 100% ownership
    12. Pedanios GmbH – 100% ownership of a GERMAN DISTRIBUTOR; not a deal with distributor like other LPs but ownership of it all
    13. Larssen Ltd. – 100% ownership; involved with 15 cannabis industry clients, 5 in Canada
    14. Radient Tech – 16% ownership on diluted basis
    15. Micron Waste – 6.46% ownership
    16. Liquor Stores N.A. – Now Alcanna; 25% ownership non-diluted basis
    - will have 37 stores for Alberta alone planned; more will come as regulations allow
    - 5 stores did 1.3 million in sales in first 5 days of legalization
    - 3.87% dividend;
    17. HempCo Food – 52% ownership
    18. Cann Group Limited – 22.9% ownership
    19. The Green Organic Dutchman TGOD Investment – 17.62% ownership; can increase to 50%
    20. BC Northern Lights Ltd. And Urban Cultivator, Inc. – 100% ownership
    21. Anandia Labs - 100% ownership
    22. Capcium – 19.99% ownership; $10 million private placement
    23. CTT Pharmaceutical Holdings Inc.: 9.14% ownership was a private placement US$1 million 5% convertible debenture; converted 9/11/2018; The agreement includes an issuance of warrants enabling to Aurora to increase ownership to 42.5%
    24. HotHouse Consulting Inc.: LOI to acquire
    25. Malta Greenhouse: First cultivation LOI issue; EU GMP standard facility; size TBA
    26. Choom Holdings, Inc.: 8% ownership; $7 million Aurora receive 9,859,155 common shares from Choom's treasury, priced at $0.71 per share

    30. ICC Labs Inc.: 100% ownership; $1.95 per share (payable in common shares of Aurora) $290 million CAD $220USD; projected 450,000 kg of production; 26,638 consumers were registered with ICC Labs as of June 2018;
    - Columbia licenses (50 million people): ICC Labs’ Colombian subsidiary a license to cultivate psychoactive cannabis plants for medicinal purposes for domestic and international distribution; 124,000 sq. ft. greenhouse
    - ICC Labs, Inc. owns 25% of in Global Group Kalapa S.L. (“KALAPA”), a private company headquartered in Barcelona Spain with the option to acquire the remaining 75% through the end of 2018. KALAPA is the first pan-European medical consultancy specializing in treatments with cannabinoids - as owning 100% of KSK Labs, a producer and manufacturer of products based on CBD with a presale agreement with Spain based VenPharma for an initial 140,000 CBD products with the next order to be 370,000 CBD annually to be sold via 1,300 points of sale;
    - Only Uruguay publicly traded license producer; there is one other but it is a private company; licensed 550 acres for hemp CBD production and export; currently 69 acres of hemp production as of April 2018; GMP certified extraction lab in Uruguay; Domestic cannabis rec market 3.1 million people with two licensed producers;
    - ICC has deal to export CBD to Emblem; presale of 10% of ICC's CBD production in 2018
    - Deal with Nuuvera now part of Aphria to export CBDs oils/crystals; ICC subsidiary Tersum S.A., will export 150 kilograms CBD crystal in 2018 to ARA - Avanti Rx Analytics Inc., a subsidiary of Nuuvera Inc.;
    - ICC has deal with CanPharma to export to Germany CBD isolate, oils and other derivatives, as well as various medicinal tetrahydrocannabinol (THC) cannabis products, including dried flowers and cannabis extracts from facilities in Uruguay and Colombia. The export arrangement for (THC) cannabis products is subject to receipt of the requisite regulatory approvals and the negotiation of definitive agreements by the end of second quarter in 2018;
    - ICC has presale agreement to Mexico pharmacies 120,000 30 milliliter CBD oil bottles; Presale agreement with pharmaceutical chain in Brazil 180,000 30 milliliter of CBD oil bottles; Brazil/Mexico CBD bottles cost to produce $0.10 gram
  3. Empros 25 oktober 2018 19:04
    quote:

    Mikeydekh schreef op 25 oktober 2018 17:50:

    Maar nu even serieus. Als ik alle artikelen die ik lees een beetje kan samenvatten, komt het er bij Aurora op neer dat zij missen wat Canopy bijvoorbeeld wel heeft. Een grote partner die wil investeren en samenwerken. Dat zou de koers van Aurora heel veel goed doen.
    Gut feeling....
    Aurora kan ook "hard to get" standpunt innemen, in afwachting dat ze hun volgende (briljante) financial results kunnen voorleggen op 14/11.
  4. Empros 25 oktober 2018 19:15
    quote:

    Osho schreef op 25 oktober 2018 18:57:

    Kwam een bericht op het internet tegen. Een mooi overzicht waar Aurora allemaal bij betrokken is:

    ''Some solid facts for investors I came across this morning. I'm paying less attention to the market atm and keeping this in mind for the long haul.''

    1. Aurora Sky – 800,000 sq. ft. purpose-built greenhouse – 100,000 kg plus cannabis; $1 billion revenue; on airport property for ease of shipping; 90% licensed to produce and sell will be 100% by end of December
    2. Aurora Sun – 1.2 million sp. ft. purpose built greenhouse 120,000 kg cannabis $1 billion plus revenue under construction fully funded
    3. Aurora Nordic – 51% Aurora 49% Alfred Pedersen & Son 100,000 sq. ft. purpose built greenhouse; summer 2018; 1,000,000 sq. ft. purpose built greenhouse; 120,000 kg of cannabis; $1 billion plus revenue; now growing in Denbmark/Europe under construction fully funded
    4. Aurora Mountain - 55,200 sq. ft. purpose built greenhouse
    5. Aurora Vie – 44,000 sq. ft. purpose built greenhouse
    6. Lachute Facility - 48,000 purpose built greenhouse 4,500 kg
    7. H2 Biopharma – 100% owner; Sits on 46 acres H2 Biopharma may purchase for $136,000CAD
    8. CanniMed – 7,000 kg of production EU GMP Certified; patients 22,000; patents; Intellectual property…. came with $65 million cash
    9. MedReleaf – Markham 7,000 kg; Bradford 28,000 kg; Exeter 105,000 kg with potential to double in size; came with $256 million in cash; 40,000 patients
    10. Peloton Pharmaceuticals – 100% ownership
    11. CanvasRx Holdings – 100% ownership
    12. Pedanios GmbH – 100% ownership of a GERMAN DISTRIBUTOR; not a deal with distributor like other LPs but ownership of it all
    13. Larssen Ltd. – 100% ownership; involved with 15 cannabis industry clients, 5 in Canada
    14. Radient Tech – 16% ownership on diluted basis
    15. Micron Waste – 6.46% ownership
    16. Liquor Stores N.A. – Now Alcanna; 25% ownership non-diluted basis
    - will have 37 stores for Alberta alone planned; more will come as regulations allow
    - 5 stores did 1.3 million in sales in first 5 days of legalization
    - 3.87% dividend;
    17. HempCo Food – 52% ownership
    18. Cann Group Limited – 22.9% ownership
    19. The Green Organic Dutchman TGOD Investment – 17.62% ownership; can increase to 50%
    20. BC Northern Lights Ltd. And Urban Cultivator, Inc. – 100% ownership
    21. Anandia Labs - 100% ownership
    22. Capcium – 19.99% ownership; $10 million private placement
    23. CTT Pharmaceutical Holdings Inc.: 9.14% ownership was a private placement US$1 million 5% convertible debenture; converted 9/11/2018; The agreement includes an issuance of warrants enabling to Aurora to increase ownership to 42.5%
    24. HotHouse Consulting Inc.: LOI to acquire
    25. Malta Greenhouse: First cultivation LOI issue; EU GMP standard facility; size TBA
    26. Choom Holdings, Inc.: 8% ownership; $7 million Aurora receive 9,859,155 common shares from Choom's treasury, priced at $0.71 per share

    30. ICC Labs Inc.: 100% ownership; $1.95 per share (payable in common shares of Aurora) $290 million CAD $220USD; projected 450,000 kg of production; 26,638 consumers were registered with ICC Labs as of June 2018;
    - Columbia licenses (50 million people): ICC Labs’ Colombian subsidiary a license to cultivate psychoactive cannabis plants for medicinal purposes for domestic and international distribution; 124,000 sq. ft. greenhouse
    - ICC Labs, Inc. owns 25% of in Global Group Kalapa S.L. (“KALAPA”), a private company headquartered in Barcelona Spain with the option to acquire the remaining 75% through the end of 2018. KALAPA is the first pan-European medical consultancy specializing in treatments with cannabinoids - as owning 100% of KSK Labs, a producer and manufacturer of products based on CBD with a presale agreement with Spain based VenPharma for an initial 140,000 CBD products with the next order to be 370,000 CBD annually to be sold via 1,300 points of sale;
    - Only Uruguay publicly traded license producer; there is one other but it is a private company; licensed 550 acres for hemp CBD production and export; currently 69 acres of hemp production as of April 2018; GMP certified extraction lab in Uruguay; Domestic cannabis rec market 3.1 million people with two licensed producers;
    - ICC has deal to export CBD to Emblem; presale of 10% of ICC's CBD production in 2018
    - Deal with Nuuvera now part of Aphria to export CBDs oils/crystals; ICC subsidiary Tersum S.A., will export 150 kilograms CBD crystal in 2018 to ARA - Avanti Rx Analytics Inc., a subsidiary of Nuuvera Inc.;
    - ICC has deal with CanPharma to export to Germany CBD isolate, oils and other derivatives, as well as various medicinal tetrahydrocannabinol (THC) cannabis products, including dried flowers and cannabis extracts from facilities in Uruguay and Colombia. The export arrangement for (THC) cannabis products is subject to receipt of the requisite regulatory approvals and the negotiation of definitive agreements by the end of second quarter in 2018;
    - ICC has presale agreement to Mexico pharmacies 120,000 30 milliliter CBD oil bottles; Presale agreement with pharmaceutical chain in Brazil 180,000 30 milliliter of CBD oil bottles; Brazil/Mexico CBD bottles cost to produce $0.10 gram
    Bedankt voor het overzicht & een dikke AB van mij.

    Dit doet je nogmaals in een notedop realiseren welke enorme toekomstperspectieven ACS heeft op langere termijn.

  5. Mikeydekh 25 oktober 2018 19:49
    quote:

    Empros schreef op 25 oktober 2018 19:04:

    [...]

    Gut feeling....
    Aurora kan ook "hard to get" standpunt innemen, in afwachting dat ze hun volgende (briljante) financial results kunnen voorleggen op 14/11.

    Met deze koers heb ik toch maar even een kleine investering in Aurora gedaan. Hopelijk komt jouw onderbuikgevoel uit en kunnen we genieten van een mooie winst de komende tijd en misschien wel jaren.
  6. Empros 25 oktober 2018 21:29
    quote:

    Mikeydekh schreef op 25 oktober 2018 19:49:

    [...]

    Met deze koers heb ik toch maar even een kleine investering in Aurora gedaan. Hopelijk komt jouw onderbuikgevoel uit en kunnen we genieten van een mooie winst de komende tijd en misschien wel jaren.
    Al goed dat deze "hype" achter de rug is...hoeven we geen rekening meer mee te houden :))))

    Nu zal men iedereen afrekenen op de cijfertjes van de volgende (2/3) kwartalen...en alleen dan voorzie ik dat het institutionele kapitaal zal inspringen en gaat het hard lopen (mijn gedacht hoor).

    Iemand ander idee? Fire away!
8.264 Posts
Pagina: «« 1 ... 222 223 224 225 226 ... 414 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 910,59 +0,71%
EUR/USD 1,0771 0,00%
FTSE 100 8.433,76 +0,63%
Germany40^ 18.773,50 +0,47%
Gold spot 2.360,72 0,00%
NY-Nasdaq Composite 16.340,87 -0,03%

Stijgers

Accsys
+5,43%
CM.COM
+2,92%
NX FIL...
+2,63%
RANDST...
+2,61%
ForFar...
+2,43%

Dalers

Kendrion
-2,99%
UMG
-2,95%
Alfen ...
-2,63%
EBUSCO...
-2,29%
VIVORY...
-1,85%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links